| Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis M Drolet, É Bénard, N Pérez, M Brisson, H Ali, MC Boily, V Baldo, ... The Lancet 394 (10197), 497-509, 2019 | 738 | 2019 |
| Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries M Brisson, JJ Kim, K Canfell, M Drolet, G Gingras, EA Burger, D Martin, ... The Lancet 395 (10224), 575-590, 2020 | 493 | 2020 |
| Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries K Canfell, JJ Kim, M Brisson, A Keane, KT Simms, M Caruana, EA Burger, ... The Lancet 395 (10224), 591-603, 2020 | 375 | 2020 |
| The projected timeframe until cervical cancer elimination in Australia: a modelling study MT Hall, KT Simms, JB Lew, MA Smith, JML Brotherton, M Saville, ... The Lancet Public Health 4 (1), e19-e27, 2019 | 361 | 2019 |
| Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study KT Simms, J Steinberg, M Caruana, MA Smith, JB Lew, I Soerjomataram, ... The lancet oncology 20 (3), 394-407, 2019 | 357 | 2019 |
| Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic … M Brisson, É Bénard, M Drolet, JA Bogaards, I Baussano, S Vänskä, M Jit, ... The Lancet Public Health 1 (1), e8-e17, 2016 | 276 | 2016 |
| Premenopausal bone loss in the lumbar spine and neck of femur: a study of 225 Caucasian women A Rodin, B Murby, MA Smith, M Caleffi, I Fentiman, MG Chapman, ... Bone 11 (1), 1-5, 1990 | 194 | 1990 |
| Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National … JB Lew, KT Simms, MA Smith, M Hall, YJ Kang, XM Xu, M Caruana, ... The Lancet Public Health 2 (2), e96-e107, 2017 | 169 | 2017 |
| Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study KT Simms, SJB Hanley, MA Smith, A Keane, K Canfell The Lancet Public Health 5 (4), e223-e234, 2020 | 141 | 2020 |
| Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of … MA Smith, B Liu, P McIntyre, R Menzies, A Dey, K Canfell The Journal of Infectious Diseases 211 (1), 91-99, 2015 | 104 | 2015 |
| Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies K Canfell, JF Shi, JB Lew, R Walker, FH Zhao, L Simonella, JF Chen, ... Vaccine 29 (13), 2487-2494, 2011 | 100 | 2011 |
| “Not hiding, not shouting, just me”: Gay men negotiate their visual identities V Clarke, M Smith Journal of Homosexuality 62 (1), 4-32, 2015 | 93 | 2015 |
| Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study JF Shi, K Canfell, JB Lew, FH Zhao, R Legood, Y Ning, L Simonella, L Ma, ... BMC cancer 11, 1-18, 2011 | 86 | 2011 |
| Vulvar cancer in highincome countries: Increasing burden of disease YJ Kang, M Smith, E Barlow, K Coffey, N Hacker, K Canfell International journal of cancer 141 (11), 2174-2186, 2017 | 85 | 2017 |
| Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: example from Australia MT Hall, KT Simms, JB Lew, MA Smith, M Saville, K Canfell PloS one 13 (2), e0185332, 2018 | 74 | 2018 |
| The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia MA Smith, JB Lew, RJ Walker, JML Brotherton, C Nickson, K Canfell Vaccine 29 (48), 9112-9122, 2011 | 74 | 2011 |
| Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand JB Lew, K Simms, M Smith, H Lewis, H Neal, K Canfell PLoS One 11 (5), e0151619, 2016 | 73 | 2016 |
| The predicted impact of vaccination on human papillomavirus infections in Australia MA Smith, K Canfell, JML Brotherton, JB Lew, RV Barnabas International Journal of Cancer 123 (8), 1854-1863, 2008 | 69 | 2008 |
| Projected time to elimination of cervical cancer in the USA: a comparative modelling study EA Burger, MA Smith, J Killen, S Sy, KT Simms, K Canfell, JJ Kim The Lancet Public Health 5 (4), e213-e222, 2020 | 66 | 2020 |
| Will cervical screening remain costeffective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries KT Simms, MA Smith, JB Lew, HC Kitchener, PE Castle, K Canfell International journal of cancer 139 (12), 2771-2780, 2016 | 64 | 2016 |
Sarah J (Sally) LordNHMRC Clinical Trials Centre, The University of Sydney在 sydney.edu.au 的电子邮件经过验证
Sarah J (Sally) LordNHMRC Clinical Trials Centre, The University of Sydney在 sydney.edu.au 的电子邮件经过验证
Alison Gibberd在 unswalumni.com 的电子邮件经过验证